ADAM22 Antibodies

Santa Cruz Biotechnology provides a broad selection of ADAM22 monoclonal antibodies for investigating ADAM22's role in various biological processes. ADAM22 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ADAM22 is a member of the ADAM (A Disintegrin and Metalloproteinase) family, which plays a crucial role in cell-cell interactions and signaling pathways. ADAM22 functions primarily in the nervous system, where it influences synaptic function and neuronal development. Research has shown that ADAM22 alterations can lead to various neurological disorders. Understanding ADAM22's molecular mechanisms and functions can provide valuable insights into potential therapeutic strategies. Investigating ADAM22's role in neural development and disease progression continues to be an active area of research. Current studies focus on understanding how ADAM22 regulates synaptic transmission and neuronal connectivity. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of ADAM22's role in neurological health and disease.